BK virus immunity in patients undergoing hematopoietic stem cell transplant.
Hematopoietic stem cell transplant (HSCT) is an important modality of treatment for hematological diseases and cancers. Latent BK virus (BKV) infection is found in more than 90% of the world’s population. A challenging complication associated with BKV reactivation in HSCT patients is hemorrhagic cys...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project (FYP) |
| Language: | English |
| Published: |
2011
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/44855 |